Native kidney biopsy in pregnancy and postpartum: A single centre experience from India.

IF 0.8 Q4 OBSTETRICS & GYNECOLOGY

Obstetric Medicine Pub Date : 2024-10-24 DOI:10.1177/1753495X241290664

Shreya Srinivas Mondemu, Sreejith Parameswaran, Rajesh Nachiappa Ganesh, Anish Keepanasseril

{"title":"Native kidney biopsy in pregnancy and postpartum: A single centre experience from India.","authors":"Shreya Srinivas Mondemu, Sreejith Parameswaran, Rajesh Nachiappa Ganesh, Anish Keepanasseril","doi":"10.1177/1753495X241290664","DOIUrl":null,"url":null,"abstract":"Background: With the advances in medicine and imaging, renal biopsy is increasingly utilised for identifying pathologies during pregnancy.Methods: This retrospective observational study aimed to assess indications and complications among 32 women who underwent native renal biopsies during pregnancy and postpartum from 2015 to 2022.Results: The commonest indications for performing the biopsy were nephrotic syndrome and acute kidney injury during pregnancy or immediately postpartum. Most (62.5%) had biopsies performed in the antenatal period. Lupus nephritis was the most common finding on biopsy, and there were no procedure-related serious adverse effects. Most pregnancies were complicated by hypertensive disorders and preterm birth. All except six women with perinatal loss had healthy neonates.Conclusions: Even as kidney biopsy remains the gold standard for diagnosing renal pathologies, it should be reserved for women where management in pregnancy would be altered by the result.","PeriodicalId":51717,"journal":{"name":"Obstetric Medicine","volume":" ","pages":"1753495X241290664"},"PeriodicalIF":0.8000,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11563491/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetric Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1753495X241290664","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: With the advances in medicine and imaging, renal biopsy is increasingly utilised for identifying pathologies during pregnancy.

Methods: This retrospective observational study aimed to assess indications and complications among 32 women who underwent native renal biopsies during pregnancy and postpartum from 2015 to 2022.

Results: The commonest indications for performing the biopsy were nephrotic syndrome and acute kidney injury during pregnancy or immediately postpartum. Most (62.5%) had biopsies performed in the antenatal period. Lupus nephritis was the most common finding on biopsy, and there were no procedure-related serious adverse effects. Most pregnancies were complicated by hypertensive disorders and preterm birth. All except six women with perinatal loss had healthy neonates.

Conclusions: Even as kidney biopsy remains the gold standard for diagnosing renal pathologies, it should be reserved for women where management in pregnancy would be altered by the result.

查看原文本刊更多论文

孕期和产后原位肾活检：印度单个中心的经验。

背景：随着医学和影像学的发展，妊娠期肾活检越来越多地被用于识别病变：这项回顾性观察研究旨在评估2015年至2022年期间接受原位肾活检的32名孕期和产后妇女的适应症和并发症：进行活检最常见的适应症是妊娠期或产后不久的肾病综合征和急性肾损伤。大多数人（62.5%）在产前进行了活组织检查。狼疮性肾炎是活检中最常见的发现，没有与手术相关的严重不良反应。大多数孕妇都患有高血压和早产。除六名围产期死亡的妇女外，所有新生儿都很健康：尽管肾活检仍是诊断肾脏病变的金标准，但它应仅限于结果会改变妊娠管理的妇女。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Obstetric Medicine OBSTETRICS & GYNECOLOGY-

CiteScore

1.90

自引率

0.00%

发文量